• Español
Logotipo BioKeralty
  • Home
  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Contact
/ Resources / Featured news / An European Project aiming to Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tools

An European Project aiming to Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tools

Jan 31 2023
biokeraltygenerico 0 Comments

An European Project aiming to Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tools.

31 January 2023.

The Kick-off meeting of the European project OPADE was held at the EBRIS Foundation (EUROPEAN BIOMEDICAL RESEARCH INSTITUTE OF SALERNO) on 23-24th January. The project will have a duration of 54 months, ending on 31 May 2027.

The project general objective is to identify key biomarkers that support the decision-making process of the healthcare providers. The project focuses on the microbiota – brain -axis which plays a major role in mental health and in particular Major depression disorder. Through clinical investigations, the consortium partners will study the combination between genetics, epigenetics, microbiome and inflammatory networks.

An European Project aiming to Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tools.
OPADE project is 100% funded by the European Union (Horizon Europe Grant Agreement 101095436). Scientifically coordinated by EBRIS Foundation, it integrates a consortium of research centres, hospitals and enterprises from ten different countries. The consortium is completed by The CEINGE BIOTECNOLOGIE AVANZATE SCARL (Italy), PERSEUS BIOMICS (Belgium), FUNDACIO EURECAT (Spain), ARTIFICIAL INTELLIGENCE EXPERT SRL (Romania), MAMA HEALTH TECHNOLOGIES GMBH (Germany), PROTOBIOS OU (Estonia), CEPHALGO (France), BIOKERALTY RESEARCH INSTITUTE AIE (Spain), FUNDACION UNIVERSITARIA SANITAS (Colombia), UNIVERSITA DEGLI STUDI DI SIENA (Italy), STICHTING UNIVERSITAIRE EN ALGEMENE KINDER – EN JEUGDPSYCHIATRIE NOORD-NEDERLAND (The Netherlands), FUNDACIO INSTITUT D’INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA (Spain) and ISTANBUL MEDIPOL UNIVERSITESI (Turkey).

During this meeting researchers from the different organizations discussed the key issues to be addressed during the first year and the administrative procedures to ensure the success of this innovative project.

BioKeralty searches for innovative solutions able to optimize the manufacture of cornea substitutes

Prev Post

An European Project aiming to optimise Therapeutic Epigenetic Enhancement of the Innate Immunity to Effectively Combat Antimicrobial Resistance

Next Post
More news
IN-ARMOR Consortium Strategize for Upcoming Project Review and Clinical Transitions
by YIDOSA Websites 06/01/2026
SPRI highlights Biokeralty’s participation in OPADE, the European project applying artificial intelligence to the treatment of depression
by YIDOSA Websites 06/01/2026
TEN4CARE at TERMIS-EU 2026: Advancing the Conversation on Smart Biomaterials and Regulatory Innovation
by YIDOSA Websites 05/13/2026
IN-ARMOR Project Gains International Spotlight in Iceland for its Revolutionary Approach to Antimicrobial Resistance
by YIDOSA Websites 05/12/2026
Biokeralty takes part in the final meeting of the European Convert2Green project
by YIDOSA Websites 05/12/2026

Scientific resources

Patents and publications

For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.

Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.

Awesome Image

  • C/Albert Einstein 25, Edificio E-3, 1ª planta Oficina 2

    Parque Tecnológico de Álava,

    01510 Miñano, Vitoria-Gasteiz (Álava), España

  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Legal
  • Privacy policy
  • Cookies policy
  • Contact

Copyright © BioKeralty 2023

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Logotipo BioKeralty
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Marketing

This website uses the following additional cookies:

(List the cookies that you are using on the website here.)